Table 1.
Patient characteristics.
| Dialysis Patients Post Vaccination (n = 142) |
Dialysis Patients Post COVID-19 Infection (n = 33) | Control Group (n = 104) |
|
|---|---|---|---|
| Type of dialysis | |||
| HD | 115 (81%) | 31 (94%) | |
| PD | 27 (19%) | 2 (6%) | |
| Gender | |||
| Male | 87 (61%) | 18 (55%) | 46 (44%) |
| Female | 55 (39%) | 15 (45%) | 58 (56%) |
| Age median (25–75) Range |
64 (56.7–72.3) 27–86 |
51 (41–62.5) 23–90 |
49 (40–59) 29–81 |
|
Albumin (g/dL) Range |
3.8 (3.6–4.1) 2.6–5.0 |
3.9 (3.6–4.2) 2.3–5.0 |
|
| Diabetes | 85 (60%) | 18 (54%) | |
| KT/V HD, median (25–75) KT/V PD |
1.42 (1.22–1.62) 2.2 (1.9–2.9) |
1.55 (1.22–1.76) 1.70 (1.60–1.70) |
|
| Dialysis vintage, years | 3.4 (1.8–5.3) | 3.08 (1.50–8.48) | - |
HD hemodialysis; PD-peritoneal dialysis; KT/V-dialysis adequacy.